NCT03076905View on ClinicalTrials.gov

Pharmacokinetics of IV Formulation

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

May 31, 2017

Primary Completion Date

July 31, 2017

Study Completion Date

August 31, 2017

Conditions
Invasive Aspergillosis
Interventions
DRUG

F901318

Evaluation of AUC0-t

Sponsors

Lead Sponsor

F2G Biotech GmbH

Collaborators (1)

Quotient Clinical
All Listed Sponsors
collaborator

Quotient Clinical

OTHER

lead

F2G Biotech GmbH

INDUSTRY

NCT03076905 - Pharmacokinetics of IV Formulation | Biotech Hunter | Biotech Hunter